Preclinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma (Q45893666)

From Wikidata
Jump to navigation Jump to search
scientific article published on 4 November 2015
edit
Language Label Description Also known as
English
Preclinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
scientific article published on 4 November 2015

    Statements

    Preclinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit